2024年3月21日发(作者：)

专利内容由知识产权出版社提供

专利名称：COMPOSITIONS AND METHODS FOR

TREATING CANCER WITH ANTI-CD22

IMMUNOTHERAPY

发明人：ORENTAS, Rimas J.,SCHNEIDER,

Dina,DROPULIC, Boro,DIMITROV, Dimiter

S.,ZHU, Zhongyu

申请号：US2018/056011

申请日：20181016

公开号：WO2019/079249A9

公开日：20191114

摘要：Chimeric antigen receptors (CARs) containing CD22 antigen binding domains are

disclosed. Nucleic acids, recombinant expression vectors, host cells, antigen binding

fragments, and pharmaceutical compositions, relating to the CARsare also disclosed.

Methods of treating or preventing cancer in a subject, and methods of making CAR T

cells are also disclosed.

申请人：LENTIGEN TECHNOLOGY, INC.,THE U.S.A., as represented by THE SECRETARY,

DEPARTMENT OF HEALTH AND HUMAN SERVICES

地址：910 Clopper Road, Suite 200 South Building Gaithersburg, Maryland 20878

US,6011 Executive Boulevard, Suite 325 MSC 7660 OTT, National Institutes of Health

Bethesda, Maryland 20892-7660 US

国籍：US,US

代理人：GARCIA, Todd E. et al.

更多信息请下载全文后查看